USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Revenue	899.22	854.5	921.01	998.6	1,186	1,135
Revenue Growth (YoY)	2.75%	-7.22%	-7.77%	-15.83%	4.57%	6.95%
Cost of Revenue	180.44	161.21	176.69	193.89	217.9	209.11
Gross Profit	718.78	693.29	744.32	804.71	968.57	925.53
Selling, General & Admin	662.58	626.97	651.25	697.1	798.37	749.04
Operating Expenses	662.58	626.97	651.25	697.1	798.37	749.04
Operating Income	56.2	66.32	93.07	107.61	170.19	176.49
Interest Expense	-0.85	-0.28	-0.26	-0.19	-0.06	-0.51
Interest & Investment Income	7.22	11.32	9.64	3.79	2.52	2.54
Other Non Operating Income (Expenses)	2.02	-1.01	0.01	-2.59	-2.01	-0.57
Pretax Income	64.59	76.35	102.45	108.62	170.64	177.95
Income Tax Expense	29.77	34.29	38.67	39.27	54.14	53.28
Earnings From Continuing Operations	34.83	42.06	63.79	69.35	116.51	124.66
Minority Interest in Earnings	-0.71	-0.03	-	-	-	-
Net Income	34.12	42.03	63.79	69.35	116.51	124.66
Net Income to Common	34.12	42.03	63.79	69.35	116.51	124.66
Net Income Growth	-38.06%	-34.11%	-8.02%	-40.48%	-6.54%	24.01%
Shares Outstanding (Basic)	19	19	19	19	20	21
Shares Outstanding (Diluted)	19	19	19	19	20	21
Shares Change (YoY)	-1.65%	-0.95%	0.18%	-5.08%	-4.29%	-6.84%
EPS (Basic)	1.80	2.20	3.31	3.60	5.78	5.89
EPS (Diluted)	1.80	2.19	3.30	3.59	5.73	5.86
EPS Growth	-37.19%	-33.64%	-8.08%	-37.35%	-2.22%	32.88%
Free Cash Flow	50.99	50.92	56.15	93.5	108.46	145.31
Free Cash Flow Per Share	2.69	2.66	2.90	4.84	5.33	6.84
Gross Margin	79.93%	81.13%	80.81%	80.58%	81.64%	81.57%
Operating Margin	6.25%	7.76%	10.11%	10.78%	14.34%	15.55%
Profit Margin	3.79%	4.92%	6.93%	6.94%	9.82%	10.99%
Free Cash Flow Margin	5.67%	5.96%	6.10%	9.36%	9.14%	12.81%
EBITDA	79.85	80.86	105.77	121.01	183.23	190.24
EBITDA Margin	8.88%	9.46%	11.48%	12.12%	15.44%	16.77%
D&A For EBITDA	23.65	14.54	12.7	13.39	13.04	13.75
EBIT	56.2	66.32	93.07	107.61	170.19	176.49
EBIT Margin	6.25%	7.76%	10.11%	10.78%	14.34%	15.55%
Effective Tax Rate	46.09%	44.91%	37.74%	36.15%	31.72%	29.94%
Advertising Expenses	-	4.97	4.76	5.05	12.4	9.85

Updated Jul 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q